Denise Bevers Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Denise Bevers.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Denise Bevers. Denise Bevers is a Chief Financial Officer in Kindred Biosciences, Inc. ($KIN) and a Chief Operating Officer in Kindred Biosciences, Inc. ($KIN) and a Director in Kindred Biosciences, Inc. ($KIN) and a President & COO in Kindred Biosciences, Inc. ($KIN) and a President and COO in Kindred Biosciences, Inc. ($KIN).

Address: C/O KINDRED BIOSCIENCES, INC. 1499 BAYSHORE HIGHWAY, SUITE 226 BURLINGAME 94010 CA

Companies in which Denise Bevers is an Insider

Kindred Biosciences, Inc.

Trading Symbol: KIN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Denise Bevers: Director, President & COO, President and COO, Chief Financial Officer, Chief Operating Officer
Holdings: 8,396 shares
Current Value: $53,734
Latest Transaction: Mar 18 2021
$KIN Market Capitalization: $126.31M
$KIN Previous Close: $6.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Denise Bevers

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 18 2021KINKindred Bioscience ...Bevers DeniseDirectorOption ExerciseM0.328,3962,6870
Mar 18 2021KINKindred Bioscience ...Bevers DeniseDirectorSellS5.008,39641,99708.4 K to 0 (-100.00 %)
Mar 18 2021KINKindred Bioscience ...Bevers DeniseDirectorBuyM0.328,3962,6878,3960 to 8.4 K
Feb 23 2021KINKindred Bioscience ...Bevers DeniseDirectorOption ExerciseM0.324,6221,4798,396
Feb 23 2021KINKindred Bioscience ...Bevers DeniseDirectorOption ExerciseM0.325213,081
Feb 23 2021KINKindred Bioscience ...Bevers DeniseDirectorSellS5.004,62223,11004.6 K to 0 (-100.00 %)
Feb 23 2021KINKindred Bioscience ...Bevers DeniseDirectorBuyM0.324,6221,4794,6220 to 4.6 K

View all Denise Bevers insider transactions.